SODIUM BICARBONATE Drug Patent Profile
✉ Email this page to a colleague
When do Sodium Bicarbonate patents expire, and when can generic versions of Sodium Bicarbonate launch?
Sodium Bicarbonate is a drug marketed by Exela Pharma, Hospira, Intl Medication Sys, Long Grove Pharms, Omnivium Pharms, Steriscience, and Abbott. and is included in twelve NDAs.
The generic ingredient in SODIUM BICARBONATE is sodium bicarbonate. There are one thousand four hundred and seventy-two drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the sodium bicarbonate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Sodium Bicarbonate
A generic version of SODIUM BICARBONATE was approved as sodium bicarbonate by HOSPIRA on March 4th, 2016.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SODIUM BICARBONATE?
- What are the global sales for SODIUM BICARBONATE?
- What is Average Wholesale Price for SODIUM BICARBONATE?
Summary for SODIUM BICARBONATE
| US Patents: | 0 |
| Applicants: | 7 |
| NDAs: | 12 |
| Finished Product Suppliers / Packagers: | 16 |
| Raw Ingredient (Bulk) Api Vendors: | 168 |
| Clinical Trials: | 264 |
| Drug Prices: | Drug price information for SODIUM BICARBONATE |
| DailyMed Link: | SODIUM BICARBONATE at DailyMed |
Recent Clinical Trials for SODIUM BICARBONATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Indiana University | Phase 4 |
| Taipei Medical University Shuang Ho Hospital | Phase 2 |
| University of Southern California | Phase 2 |
Pharmacology for SODIUM BICARBONATE
| Drug Class | Osmotic Laxative |
| Mechanism of Action | Osmotic Activity Alkalinizing Activity |
| Physiological Effect | Increased Large Intestinal Motility Inhibition Large Intestine Fluid/Electrolyte Absorption |
Anatomical Therapeutic Chemical (ATC) Classes for SODIUM BICARBONATE
US Patents and Regulatory Information for SODIUM BICARBONATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Exela Pharma | SODIUM BICARBONATE | sodium bicarbonate | INJECTABLE;INJECTION | 211091-001 | Jun 20, 2019 | AP | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Hospira | SODIUM BICARBONATE | sodium bicarbonate | INJECTABLE;INJECTION | 202494-001 | Mar 6, 2017 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Hospira | SODIUM BICARBONATE | sodium bicarbonate | INJECTABLE;INJECTION | 202679-001 | Mar 7, 2017 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
